JP2019517586A5 - - Google Patents

Download PDF

Info

Publication number
JP2019517586A5
JP2019517586A5 JP2019516085A JP2019516085A JP2019517586A5 JP 2019517586 A5 JP2019517586 A5 JP 2019517586A5 JP 2019516085 A JP2019516085 A JP 2019516085A JP 2019516085 A JP2019516085 A JP 2019516085A JP 2019517586 A5 JP2019517586 A5 JP 2019517586A5
Authority
JP
Japan
Prior art keywords
substituted
release composition
sustained release
poly
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019516085A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019517586A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/035874 external-priority patent/WO2017210668A1/en
Publication of JP2019517586A publication Critical patent/JP2019517586A/ja
Publication of JP2019517586A5 publication Critical patent/JP2019517586A5/ja
Pending legal-status Critical Current

Links

JP2019516085A 2016-06-03 2017-06-05 カッパオピオイド受容体アゴニストの持続放出組成物 Pending JP2019517586A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662345583P 2016-06-03 2016-06-03
US62/345,583 2016-06-03
PCT/US2017/035874 WO2017210668A1 (en) 2016-06-03 2017-06-05 Sustained release compositions of kappa-opioid receptor agonist

Publications (2)

Publication Number Publication Date
JP2019517586A JP2019517586A (ja) 2019-06-24
JP2019517586A5 true JP2019517586A5 (https=) 2020-07-27

Family

ID=60478002

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019516085A Pending JP2019517586A (ja) 2016-06-03 2017-06-05 カッパオピオイド受容体アゴニストの持続放出組成物

Country Status (5)

Country Link
US (1) US20200316159A1 (https=)
EP (1) EP3463306A4 (https=)
JP (1) JP2019517586A (https=)
CN (1) CN109789094A (https=)
WO (1) WO2017210668A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20260007295A (ko) 2018-05-24 2026-01-13 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
MX2020012459A (es) 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
WO2021026492A1 (en) 2019-08-07 2021-02-11 Humanwell Pharmaceutical US Kappa opioid receptor peptide amide agonists
AU2021236662A1 (en) * 2020-03-18 2022-11-10 Cara Therapeutics, Inc. Oligosaccharide formulations of kappa opioid receptor agonists
EP4175944A4 (en) 2020-06-25 2024-03-06 Humanwell Pharmaceutical US PEPTIDES FOR THE TREATMENT OF MEDICAL DISORDERS
WO2022221862A1 (en) * 2021-04-14 2022-10-20 Titan Pharmaceuticals, Inc. Kappa-opioid receptor agonist implants for treatment of pruritus
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular
CN114873741B (zh) * 2022-05-31 2023-03-14 南京大学 一种脱氮缓释碳源材料及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2561860T1 (en) * 2002-05-31 2018-05-31 Titan Pharmaceuticals, Inc. An implantable polymeric device for prolonged release of buprenorphine
EP2040733A2 (en) * 2006-05-26 2009-04-01 Cara Therapeutics, Inc. Method for elevating prolactin in mammals
US7842662B2 (en) * 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
RU2500685C2 (ru) * 2006-11-10 2013-12-10 Кара Терапеутикс, Инк Синтетические пептидные амиды
CA2685720C (en) * 2007-05-01 2016-07-05 Fundacao De Amparo A Pesquisa Do Estado De Sao Paulo - Fapesp Analgesic compounds
CN107308124A (zh) * 2010-09-02 2017-11-03 格吕伦塔尔有限公司 包含阴离子聚合物的抗破碎剂型
JP2016506391A (ja) * 2012-12-06 2016-03-03 ステルス ペプチドズ インターナショナル インコーポレイテッド ペプチド治療薬およびその使用方法

Similar Documents

Publication Publication Date Title
JP2019517586A5 (https=)
JP2012525393A5 (https=)
RU2428985C2 (ru) Лекарственная форма, содержащая оксикодон и налоксон
RU2445312C2 (ru) ПРОИЗВОДНЫЕ 2-МЕТИЛМОРФОЛИН ПИРИДО-, ПИРАЗО- И ПИРИМИДО-ПИРИМИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ mTOR
JP2016539134A5 (https=)
US11058638B2 (en) Tyrosine derivatives and compositions comprising them
JP2018524298A5 (https=)
RU2014111069A (ru) Лекарственные формы ингибитора гистондиацетилазы в комбинации с бендамутином и их применение
JP2017518334A5 (https=)
RU2012141951A (ru) Курс лечения с использованием агониста рецептора sip
JP2010077141A5 (https=)
RU2011138962A (ru) Производные 4-изопропилфенилглюцита в качестве ингибиторов sglt1
EP1858516A1 (en) Pharmaceutical compositions for the treatment and/or prevention of depression
JP2005525369A5 (https=)
JP2009537550A5 (https=)
JP2007520452A5 (https=)
EP3030238B1 (en) Methods of treating pruritic conditions mediated through histamine h-4 receptors
RU2013141559A (ru) Способ ингибирования клеток опухоли гамартомы
JP2019511204A (ja) コパンリシブバイオマーカー
JP2006518731A5 (https=)
KR101307650B1 (ko) 구역에 대한 경피 방법 및 패치
US20230257471A1 (en) Cancer treatment
JP2011518168A5 (https=)
JP2019052094A5 (https=)
US20220031657A1 (en) Pharmaceutical combination comprising lsz102 and ribociclib